Oxford Pharmascience Group (OXP)

 

Latest News

All resolutions passed at AGM of Oxford Pharmascience

Oxford Pharmascience Group has confirmed that all resolutions were passed by shareholders at today's Annual General M...

Result of AGM

RNS Number: 4736I Oxford Pharmascience Group PLC 19 June 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Result of AGM Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, is pleased to announce that at its Annual Ge...

Further Update re: OXPzero Ibuprofen Programmes

RNS Number: 5108H Oxford Pharmascience Group PLC 08 June 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the " Company ") Further Update R egarding OXPzero TM Ibuprofen Programmes Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easie...

Update regarding OXPzeroTM Ibuprofen Programmes

RNS Number: 5321E Oxford Pharmascience Group PLC 09 May 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Update regarding OXPzeroTM Ibuprofen Programmes Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, pr...

All News

DateHeadlineSource
19-06-17All resolutions passed at AGM of Oxford PharmascienceStockMarketWire
19-06-17Result of AGMRNS
08-06-17Further Update re: OXPzero Ibuprofen ProgrammesRNS
09-05-17Update regarding OXPzeroTM Ibuprofen ProgrammesRNS
31-03-17Miners drag on FTSE as commodity prices fall StockMarketWire
31-03-17Second Price Monitoring ExtnRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Price Monitoring ExtensionRNS
31-03-17Oxford Pharmascience disappointed with FDA feedbackStockMarketWire
31-03-17FDA Feedback on OXPzeroT Ibuprofen Rx ProgrammeRNS
10-03-17Oxford Pharmascience narrows FY pretax lossStockMarketWire
10-03-17Final ResultsRNS
07-03-17Notice of ResultsRNS
23-02-17Company UpdateRNS
25-01-17Oxford Pharmascience - Company updateBRR Media
17-01-17Oxford Pharmascience issues company updateStockMarketWire
17-01-17Company UpdateRNS
09-11-16R&D UpdateRNS
19-10-16Here's what Neil Woodford is buying and sellingInteractive Investor
13-09-16Oxford Pharmascience - Interim results 2016BRR Media
07-09-16Interim results for the 6 months to 30 June 2016RNS
21-07-16Oxford Pharmascience downgraded by BeaufortStockMarketWire
21-07-16Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLCStockMarketWire
20-07-16FTSE rises on pharmas, financials as miners ebbStockMarketWire
20-07-16Commercial Update & Directorate ChangeRNS
22-06-16Result of AGMRNS
20-05-16Shares Magazine Investor Evening PresentationRNS
22-04-16OXP to exhibit at the Master Investor Show 2016RNS
22-04-16Oxford Pharmascience Group plc - Company updateBRR Media
19-04-16Positive Regulatory Advice from MHRARNS
11-03-16Grant of Share OptionsRNS
04-03-16Oxford Pharmascience widens FY pretax lossStockMarketWire
04-03-16Final ResultsRNS
01-03-16Oxford Pharmascience schedules FY results StockMarketWire
01-03-16Notice of ResultsRNS
25-02-16Appointment of DirectorRNS
29-01-16Change of Registered OfficeRNS
25-01-16OXP primed for partnering talks on OXPzero NSAIDSStockMarketWire
25-01-16Entering Partnering DiscussionsRNS
04-12-15Oxford Pharmascience CFO granted share optionsStockMarketWire

RSS feeds

  • Editorial news feed for LSE:OXP Editorial
  • Regulatory news feed for LSE:OXP Regulatory